<DOC>
	<DOCNO>NCT01791972</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy single dose ( 2 inhalation , 180 mcg total ) Albuterol SPIROMAX ( 90 mcg per inhalation ) versus placebo patient EIB .</brief_summary>
	<brief_title>Efficacy Albuterol SPIROMAX® Adult Adolescent Patients With Exercise-Induced Bronchoconstriction ( EIB )</brief_title>
	<detailed_description>This study single-dose , randomize , double-blind , placebo-controlled , 2-treatment , 2-sequence , 2-way crossover , multicenter study patient document history EIB , without underlie asthma . Each patient participate study approximately 5 week . Each patient complete 2 screen visit ( SV1 SV2 ) , 2 treatment visit ( TV1 TV2 ) , follow-up telephone call ( FV ) .</detailed_description>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Informed consent/assent : For patient 18 50 year age , inclusive , write informed consent sign dated patient conduct study related procedure review Health Insurance Portability Accountability Act 1996 ( HIPAA ) authorization ; patient 12 17 year age , inclusive , write informed consent sign dated parent/legal guardian write assent sign dated patient conduct study related procedure review HIPAA authorization . Male female patient 12 50 year age , inclusive , SV1 . If female , currently pregnant , breastfeeding , attempt become pregnant , negative serum pregnancy test , nonchildbearing potential . Documented history EIB , without underlie asthma . The underlying asthma must wellcontrolled ( investigator 's judgment ) per National Asthma Education Prevention Program , Expert Panel Report ( NAEPP , EPR3 ) . Other criterion apply . Requires rescue bronchodilator follow exercise challenge SV1 decrease FEV1 return within 20 % preexercise challenge FEV1 within 30 minute administration rescue medication . Pregnant , nursing , plan become pregnant donate gamete ( ova sperm ) vitro fertilization study period 30 day patient 's last study relate visit ( eligible patient onlyif applicable ) . Participation investigational drug trial within 30 day precede SV1 plan participation another investigational drug trial time trial . A known hypersensitivity albuterol excipients formulation . History severe milk protein allergy . History respiratory infection disorder ( include , limited bronchitis , pneumonia , otitis medium , acute chronic sinusitis , influenza , etc ) resolve within 2 week precede SV1 . Other criterion apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Exercise-Induced Bronchoconstriction ( EIB )</keyword>
	<keyword>Spiromax®</keyword>
	<keyword>Albuterol sulfate</keyword>
</DOC>